Strand Displacement Amplification Market Analysis

  • Report ID: 5259
  • Published Date: Sep 25, 2023
  • Report Format: PDF, PPT

Strand Displacement Amplification Market Analysis

Application (Tuberculosis, Hepatitis, Malaria, Influenza, Cancer)

Strand displacement amplification market from the cancer segment is set to observe the highest revenue share of 35% by the end of 2036. One of the key elements fuelling the segment's expansion is the rising incidence of cancer in the world. For instance, China is seeing a higher prevalence of malignancies, according to the data released in March 2022. The number of instances of new cancer in China in 2022 was predicted to be 4,820,000, with lung cancer being the most prevalent type.

End User (Hospitals, Diagnostics, Laboratories)

In terms of end users, the diagnostic laboratories segment is poised to account for the largest market share during the time period between 2024 – 2036. The growth of this segment can be ascribed to the increasing values of nucleic acid amplification in the healthcare domain. Additionally, strand displacement amplification technology is being utilized by research laboratories majorly by forensic labs, and is expected to boost the segment growth in the future times.

Our in-depth analysis of the global market includes the following segments:

           Product Type

  • Instruments
  • Reagents & Consumables

           Application

  • Tuberculosis
  • Hepatitis
  • Malaria
  • Influenza
  • Cancer

            End User

  • Hospitals
  • Diagnostics Laboratories

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5259
  • Published Date: Sep 25, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of infectious diseases and increasing awareness about the benefits of strand displacement amplification are some of the major factors anticipated to drive the growth of the strand displacement amplification market.

The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2024 – 2036.

The major players in the market are Sherlock Biosciences, Lucigen Corporation, Bio-Rad Laboratories Inc., G-Biosciences, New England Bio-Labs, Geno Technologies Inc., and others.

The diagnostic laboratories segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying